Precision BioSciences Q1 EPS $1.70 Beats $(1.91) Estimate, Sales $17.58M Beat $6.02M Estimate
Precision BioSciences Q1 EPS $1.70 Beats $(1.91) Estimate, Sales $17.58M Beat $6.02M Estimate
Precision BioSciences第一季度每股收益1.70美元，超過預期（1.91美元），銷售額1758萬美元超過602萬美元的預期
Precision BioSciences (NASDAQ:DTIL) reported quarterly earnings of $1.70 per share which beat the analyst consensus estimate of $(1.91) by 189.01 percent. This is a 124.64 percent increase over losses of $(6.90) per share from the same period last year. The company reported quarterly sales of $17.58 million which beat the analyst consensus estimate of $6.02 million by 192.09 percent. This is a 100.27 percent increase over sales of $8.78 million the same period last year.
Precision BioSciences（納斯達克股票代碼：DTIL）公佈的季度收益爲每股1.70美元，比分析師普遍預期的1.91美元（1.91美元）高出189.01％。與去年同期每股虧損6.90美元（6.90）相比，增長了124.64％。該公司公佈的季度銷售額爲1758萬美元，比分析師普遍預期的602萬美元高出192.09％。這比去年同期的878萬美元的銷售額增長了100.27％。